These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 362064

  • 1. [Use of "Essenciale" in the treatment of liver diseases].
    Pogromov AP, Ol'binskaia LI, Antonenko NI, Gitel' NP, Smolianitskiĭ AIa.
    Klin Med (Mosk); 1978 Oct; 56(10):97-101. PubMed ID: 362064
    [No Abstract] [Full Text] [Related]

  • 2. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS, Nikolaeva AP, Bendikov EA, Blok IuE, Sukhareva GV.
    Sov Med; 1989 Oct; (7):79-81. PubMed ID: 2799537
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS, Dzhalalov KD, Blok IuE, Bendikov EA, Ausheva LKh.
    Ter Arkh; 1986 Oct; 58(2):73-6. PubMed ID: 3704945
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Silymarin in chronic liver diseases].
    Müscher CH.
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract] [Full Text] [Related]

  • 7. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R, Arcangeli A, Salvadori G, Smorlesi C, Di Perri T, Auteri A, Boggiano CA, Pippi L, Toti M, Boncompagni P, Angioli D, Caremani M, Magnolfi F, Camarri E, Motta R, Forconi A, Candidi Tommasi A, Lomi M, Soldi A.
    Minerva Med; 1978 Oct 13; 69(48):3283-92. PubMed ID: 724140
    [No Abstract] [Full Text] [Related]

  • 8. [Use of ornithine carbamoyltransferase in the treatment of liver diseases].
    Caruso N, De Jacobis M, Roccato M, Sequino A, Sgoifo B, Tinello M.
    Clin Ter; 1984 Jul 15; 110(1):37-44. PubMed ID: 6237844
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Thiomesterone and liver function].
    Pickert H.
    Med Klin; 1968 Aug 02; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A, Tsvetkova V, Krŭstev Z, Kostova N, Lukanov L.
    Vutr Boles; 1985 Aug 02; 24(5):39-43. PubMed ID: 4090451
    [No Abstract] [Full Text] [Related]

  • 12. [Essential choline phospholipids and their effect on HBsAg and selected biochemical tests in cirrhosis of the liver (author's transl)].
    Fassati P, Horejsí J, Fassati M, Spízek J, Jezková Z.
    Cas Lek Cesk; 1981 Jan 22; 120(2):56-60. PubMed ID: 7471152
    [No Abstract] [Full Text] [Related]

  • 13. [Use of the preparation Essenciale in chronic ischemic heart disease].
    Kukes VG, Senik EA, Gneushev ET, Potekaeva SA, Milovanova NM.
    Kardiologiia; 1978 Jun 22; 18(6):79-82. PubMed ID: 353358
    [Abstract] [Full Text] [Related]

  • 14. [Clinical experimentation with Aïcamine in hepatic insufficiency].
    Négret JP.
    Bord Med; 1972 Apr 22; 5(8):973-6. PubMed ID: 5053280
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical experience report on Hepavis].
    Menninger U, Menninger W.
    Med Welt; 1980 Oct 17; 31(42):1519-21. PubMed ID: 7453534
    [No Abstract] [Full Text] [Related]

  • 16. [Lecithin-cholesterol-acyltransferase activity in chronic liver diseases].
    Gaskina TK, Dolgov AV, Kurilovich SA.
    Vopr Med Khim; 1987 Oct 17; 33(4):96-9. PubMed ID: 3660750
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of liver diseases, especially of fatty liver with betaine citrate].
    Semmler F.
    Ther Ggw; 1977 Nov 17; 116(11):2113-24. PubMed ID: 337559
    [No Abstract] [Full Text] [Related]

  • 18. Gut-liver axis: a new point of attack to treat chronic liver damage?
    Loguercio C, De Simone T, Federico A, Terracciano F, Tuccillo C, Di Chicco M, Cartenì M.
    Am J Gastroenterol; 2002 Aug 17; 97(8):2144-6. PubMed ID: 12190198
    [No Abstract] [Full Text] [Related]

  • 19. [Use of essentiale in chronic liver diseases in patients with pulmonary tuberculosis].
    Blikhar EM, Skakun NP.
    Probl Tuberk; 1988 Aug 17; (3):41-4. PubMed ID: 3387393
    [No Abstract] [Full Text] [Related]

  • 20. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
    Pfliegler G, Boda Z, Dalmi L, Weisz G, Misz M, Beck P.
    Ther Hung; 1984 Aug 17; 32(1):19-25. PubMed ID: 6571189
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.